TEAM UP: Defining and Refining Optimal HIV Care During the COVID-19 Pandemic

Released On
March 2, 2021

Expires On
March 2, 2022

Media Type
Internet

Completion Time
90 minutes

Specialty
Critical Care, Emergency Medicine, Infectious Disease, Pharmacy, Primary Care

Topic(s)
AIDS/HIV

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by The Annenberg Center for Health Sciences at Eisenhower.

This educational activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Credit Available

  • Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)
  • ACPE - maximum of 1.5 contact hours
  • Nurses — 1.5 Contact Hours

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity was developed for a national audience of HIV specialists, infectious disease physicians, primary care physicians, and pharmacists.

Program Overview

During the COVID-19 pandemic, people living with HIV may have unique clinical, emotional, and social needs. For many long-term survivors with HIV, COVID-19 is the second pandemic that they have lived through. In this multipart program, experts from DAP Health will review key components of HIV care during the COVID-19 pandemic. Through webinars and short interviews, Drs. Christopher Foltz and Shubha Kerkar review COVID-19 testing, diagnosis, and management, with a focus on people living with HIV. C.J. Tobe provides guidance for clinicians addressing challenges with access to HIV care during the COVID-19 pandemic, as well as patient education and community outreach for medical underserved communities. Finally, Dr Gover is interviewed about the mental health needs of people living with HIV during COVID-19, including those of long-term survivors and caregivers.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the current understanding of the consequences of COVID-19 on persons living with HIV (PLWH)
  • Discuss strategies to ensure that all PLWH have safe access to COVID-19 testing
  • Summarize strategies to ensure that the PLWH with COVID-19 continue to receive optimal HIV care while being treated for COVID-19
  • Explain the current management of COVID-19 in PLWH
  • Outline methods to address the mental health needs of PLWH during the COVID-19 pandemic
  • Identify COVID-19-related challenges that could hinder access to HIV care and retention in HIV care
  • List culturally competent opportunities to educate communities at high-risk for HIV and COVID-19 on prevention, screening, and treatment strategies

Faculty

FACULTY_NAME

Christopher Foltz MD, AAHIVS

HIV Primary Care and Infectious Disease Physician
DAP Health
Palm Springs, California

FACULTY_NAME

Jill Gover, PhD

Behavioral Health Manager
Licensed Clinical Psychologist
DAP Health
Palm Springs, California

FACULTY_NAME

Shubha Kerkar, MD, FACP, AAHIVS, FIDSA

Director of Infectious Disease
DAP Health
Palm Springs, California

FACULTY_NAME

C.J. Tobe

Director of Community Health
DAP Health
Palm Springs, California

 

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. A maximum of 1.5 contact hours may be earned for successful completion of this activity.

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program # 0797-0000-21-023-H02-P. This program is designated for up to 1.5 contact hours (0.15 CEUs) of continuing pharmacy education credit.

 

Disclosures of Conflicts of Interest

Faculty

Christopher Foltz MD, AAHIVMS

  • Advisory Board: Gilead Sciences
  • Speakers Bureau: ViiV

Jill Gover, PhD has no relevant financial relationships to disclose.

Shubha Kerkar, MD AAHIVMS has no relevant financial relationships to disclose.

C.J. Tobe has no relevant financial relationships to disclose.

Additional Content Planners

The following have no significant relationship to disclose:
Jessica Martin, PhD (medical writer)
Coy Flowers, MD, FACOG (peer reviewer)

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Submit the evaluation form.
Certificates will be emailed to the participant

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

The faculty for this activity have disclosed that there will be no discussion about the use of products for non-FDA approved applications.

Disclaimer

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

Contact Information

For help or questions about this activity please contact Continuing Education:
ce@annenberg.net
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
Phone 760-773-4500
Fax 760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday